Press Releases

SAN FRANCISCO, Aug. 13, 2019 /PRNewswire/ -- Today, Presidio Health, a healthcare technology and clinical intelligence company, announced the general availability of hospitalist coding and business intelligence functionality in their PerformMD™ and PerformCycle™ solutions.  "We are very pleased with the response

ORLANDO, Fla., Aug. 13, 2019 /PRNewswire/ -- Medek Health Systems announces campaign to provide a no-cost team doctor for small business. As healthcare costs continue

SILICON VALLEY, Calif., Aug. 13, 2019 /PRNewswire/ -- RSIP Vision announces today that Moshe Safran has been named CEO of the new RSIP Vision USA offices based in Silicon Valley.

BOSTON, Aug. 13, 2019 /PRNewswire/ -- Debbie's Dream Foundation: Curing Stomach Cancer (DDF) will host a FREE Stomach Cancer Education Symposium and Live Webcast at Dana-Farber Cancer Institute in Boston, Massachusetts. The Symposium, designed for patients, families, caregivers, and healthcare professionals, will take place o

NEW YORK, Aug. 13, 2019 /PRNewswire/ -- According to the Mesothelioma Victims Center, "We are passionate advocates for all people with mesothelioma including those

MILWAUKEE, Wis., Aug. 13, 2019 /PRNewswire/ -- International, best-selling author Kathy Mydlach Bero garners four coveted book awards for her inspiring memoir

YARDLEY, Pa., Aug. 13, 2019 /PRNewswire/ -- Utilizing more than a decade of expertise in security and technology for healthcare clients, Intraprise Health has created BluePrint Protect™ Security Risk Management Software.  BluePrint Protect™ was created to help organizations efficiently manage and automate their security program, starting with one o

NEW YORK, Aug. 13, 2019 /PRNewswire/ -- Neurotrope, Inc. (Nasdaq: NTRP), a clinical-stage biopharmaceutical company developing novel therapies for neurodegenerative diseases, including Alzheimer's disease (AD), today announced that an article highlighting the synaptic deficiency hypothesis was published online in Trends in Pharmacological Sciences. Thi

OMAHA, Neb., Aug. 13, 2019 /PRNewswire/ -- Social Isolation is becoming an increasingly common issue, with

VANCOUVER, Aug. 13, 2019 /PRNewswire/ - Harvest One Inc. ("Harvest One" or the "Company") (TSXV: HVT; OTCQX: HRVOF), through its wholly-owned subsidiary Satipharm Ltd. ("Satipharm"), today announced positive results of a Phase 2 clinical trial of its CBD GelPell® capsules in the management of Treatment Resistant Epilepsy (TRE)